Case number 1:18-cv-08221
Valeant Pharmaceuticals North America LLC et al v. PAR Pharmaceutical, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 19 | AO 120 Form Patent - Case Terminated - Submitted (2) |
| Jul 9, 2020 | 11 | Motion to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 10 | Motion to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 9 | Motion to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 8 | Motion to Appear Pro Hac Vice (2) |
| Dec 10, 2018 | 19 | Main Document (2) Docket Text: AO 120 FORM PATENT - CASE TERMINATED - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a final decision was rendered on 12/10/2018 in a court action filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (Attachments: # (1) Notice of Voluntary Dismissal) (ne) |
| Dec 10, 2018 | 19 | Notice of Voluntary Dismissal (3) |
| Dec 10, 2018 | 18 | Notice of Voluntary Dismissal - Signed (3) Docket Text: NOTICE OF VOLUNTARY DISMISSAL WITHOUT PREJUDICE: Pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i), Plaintiffs Valeant Pharmaceuticals North America LLC ("Valeant"), Valeant Pharmaceuticals Ireland Ltd. ("Valeant Ireland"), Dow Pharmaceutical Sciences, Inc. ("Dow"), and Kaken Pharmaceutical Co., Ltd. ("Kaken") (collectively, "Plaintiffs") hereby give notice that the above-captioned action against Defendant Par Pharmaceutical, Inc. ("Par") is voluntarily dismissed without prejudice. As reflected in the attached Exhibit A, Par has represented to Plaintiffs that it has amended its ANDA No. 211742 to convert its previously submitted Paragraph IV certifications as to U.S. Patent Nos. 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,394; 9,861,698; and 9,877,955 to Paragraph III certifications. SO ORDERED. (Signed by Judge Edgardo Ramos on 12/10/2018) (ne) |
| Dec 7, 2018 | 16 | Notice of Voluntary Dismissal (3) |
| Dec 7, 2018 | 16 | Main Document (3) Docket Text: NOTICE OF VOLUNTARY DISMISSAL pursuant to Rule 41(a)(1)(A)(i) of the Federal Rules of Civil Procedure, the plaintiff(s) and or their counsel(s), hereby give notice that the above-captioned action is voluntarily dismissed, without prejudice against the defendant(s) PAR Pharmaceutical, Inc.. Document filed by All Plaintiffs. Proposed document to be reviewed and processed by Clerk's Office staff (No action required by chambers).. (Attachments: # (1) Exhibit A)(Jantzi, Nicole) |
| Dec 7, 2018 | 17 | Summons Issued (2) Docket Text: ELECTRONIC SUMMONS ISSUED as to PAR Pharmaceutical, Inc.. (dnh) |
| Dec 7, 2018 | 16 | Exhibit A (3) |
| Dec 7, 2018 | N/A | Notice to Court Regarding Voluntary Dismissal (0) Docket Text:***NOTICE TO COURT REGARDING NOTICE OF VOLUNTARY DISMISSAL Document No. [16] Notice of Voluntary Dismissal was reviewed and referred to Judge Edgardo Ramos for approval for the following reason(s): Amendement of Patent Numbers, etc., (dt) |
| Dec 5, 2018 | 15 | Request for Issuance of Summons (2) Docket Text: REQUEST FOR ISSUANCE OF SUMMONS as to Par Pharmaceutical, Inc., re: [1] Complaint,. Document filed by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (Jantzi, Nicole) |
| Oct 18, 2018 | N/A | Order on Motion to Appear Pro Hac Vice (0) Docket Text: ORDER granting [11] Motion for Paul M. Schoenhard to Appear Pro Hac Vice. (HEREBY ORDERED by Judge Edgardo Ramos)(Text Only Order) (jar) |
| Oct 18, 2018 | N/A | Order on Motion to Appear Pro Hac Vice (0) |
| Oct 18, 2018 | N/A | Order on Motion to Appear Pro Hac Vice (0) |
| Oct 12, 2018 | 11 | Main Document (2) Docket Text: AMENDED MOTION for Paul M. Schoenhard to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (Attachments: # (1) Affidavit, # (2) Exhibit Certificate of Good Standing - DC, # (3) Exhibit Certificate of Good Standing - VA, # (4) Text of Proposed Order)(Schoenhard, Paul) |
| Oct 12, 2018 | 11 | Text of Proposed Order (1) |
| Oct 12, 2018 | 11 | Exhibit Certificate of Good Standing - VA (1) |
| Oct 12, 2018 | 11 | Exhibit Certificate of Good Standing - DC (1) |
| Oct 12, 2018 | 11 | Affidavit (2) |
| Oct 12, 2018 | N/A | Notice Regarding Pro Hac Vice Motion (0) Docket Text:>>>NOTICE REGARDING PRO HAC VICE MOTION. Regarding Document No. [11] AMENDED MOTION for Paul M. Schoenhard to Appear Pro Hac Vice . Motion and supporting papers to be reviewed by Clerk's Office staff.. The document has been reviewed and there are no deficiencies. (ma) |
| Oct 1, 2018 | N/A | Notice Regarding Pro Hac Vice Motion (0) |
| Oct 1, 2018 | 8 | Affidavit (2) |
| Oct 1, 2018 | 8 | Exhibit Certificate of Good Standing - DC (1) |
| Oct 1, 2018 | 8 | Exhibit Certificate of Good Standing - MD (1) |
| Oct 1, 2018 | 8 | Text of Proposed Order (1) |
| Oct 1, 2018 | N/A | Notice Regarding Deficient Motion to Appear Pro Hac vice (0) Docket Text:>>>NOTICE REGARDING DEFICIENT MOTION TO APPEAR PRO HAC VICE. Notice to RE-FILE Document No. [9] MOTION for Paul M. Schoenhard to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-15642227. Motion and supporting papers to be reviewed by Clerk's Office staff... The filing is deficient for the following reason(s): missing Certificate of Good Standing from Supreme Court of Virginia (our court does not accept state bar certificates for Virginia). Re-file the motion as a Motion to Appear Pro Hac Vice - attach the correct signed PDF - select the correct named filer/filers - attach valid Certificates of Good Standing issued within the past 30 days - attach Attorney Affidavit - attach Proposed Order. (jc) |
| Oct 1, 2018 | 9 | Affidavit (2) |
| Oct 1, 2018 | 9 | Exhibit Certificate of Good Standing - DC (1) |
| Oct 1, 2018 | 9 | Exhibit Certificate of Good Standing - VA (1) |
| Oct 1, 2018 | 9 | Text of Proposed Order (1) |
| Oct 1, 2018 | N/A | Notice Regarding Pro Hac Vice Motion (0) |
| Oct 1, 2018 | 10 | Affidavit (2) |
| Oct 1, 2018 | 10 | Exhibit Certificate of Good Standing (1) |
| Oct 1, 2018 | 10 | Text of Proposed Order (1) |
| Oct 1, 2018 | 10 | Main Document (2) Docket Text: MOTION for Thomas P. Steindler to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-15642310. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (Attachments: # (1) Affidavit, # (2) Exhibit Certificate of Good Standing, # (3) Text of Proposed Order)(Steindler, Thomas) |
| Oct 1, 2018 | 9 | Main Document (2) Docket Text: FILING ERROR - DEFICIENT DOCKET ENTRY - MOTION for Paul M. Schoenhard to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-15642227. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (Attachments: # (1) Affidavit, # (2) Exhibit Certificate of Good Standing - DC, # (3) Exhibit Certificate of Good Standing - VA, # (4) Text of Proposed Order)(Schoenhard, Paul) Modified on 10/1/2018 (jc). |
| Oct 1, 2018 | 8 | Main Document (2) Docket Text: MOTION for Ian B. Brooks to Appear Pro Hac Vice . Filing fee $ 200.00, receipt number 0208-15642114. Motion and supporting papers to be reviewed by Clerk's Office staff. Document filed by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. (Attachments: # (1) Affidavit, # (2) Exhibit Certificate of Good Standing - DC, # (3) Exhibit Certificate of Good Standing - MD, # (4) Text of Proposed Order)(Brooks, Ian) |
| Sep 14, 2018 | N/A | Notice of Case Assignment/Reassignment (0) Docket Text: NOTICE OF CASE REASSIGNMENT to Judge Edgardo Ramos. Judge Louis L. Stanton is no longer assigned to the case. (wb) |
| Sep 11, 2018 | N/A | Case Designation (0) Docket Text: Magistrate Judge Sarah Netburn is so designated. Pursuant to 28 U.S.C. Section 636(c) and Fed. R. Civ. P. 73(b)(1) parties are notified that they may consent to proceed before a United States Magistrate Judge. Parties who wish to consent may access the necessary form at the following link: http://nysd.uscourts.gov/forms.php. (pne) |
| Sep 11, 2018 | N/A | Case Opening Initial Assignment Notice (0) Docket Text: CASE OPENING INITIAL ASSIGNMENT NOTICE: The above-entitled action is assigned to Judge Louis L. Stanton. Please download and review the Individual Practices of the assigned District Judge, located at http://nysd.uscourts.gov/judges/District. Attorneys are responsible for providing courtesy copies to judges where their Individual Practices require such. Please download and review the ECF Rules and Instructions, located at http://nysd.uscourts.gov/ecf_filing.php. (pne) |
| Sep 11, 2018 | N/A | Case Designated ECF (0) Docket Text: Case Designated ECF. (pne) |
| Sep 11, 2018 | N/A | Case Designated Patent Pilot Program (0) Docket Text: Case Eligible for Patent Pilot Program. (pne) |
| Sep 11, 2018 | 7 | Mail Patent Form (case opening) (2) Docket Text: AO 120 FORM PATENT - CASE OPENING - SUBMITTED. In compliance with the provisions of 35 U.S.C. 290, the Director of the U.S. Patent and Trademark Office is hereby advised that a court action has been filed on the following patent(s) in the U.S. District Court Southern District of New York. Director of the U.S. Patent and Trademark Office electronically notified via Notice of Electronic Filing (NEF). (pne) |
| Sep 10, 2018 | 6 | Rule 7.1 Corporate Disclosure Statement (1) Docket Text: RULE 7.1 CORPORATE DISCLOSURE STATEMENT. No Corporate Parent. Document filed by Kaken Pharmaceutical Co., Ltd..(Deni, William) |
| Sep 10, 2018 | 5 | Notice of Appearance (1) Docket Text: NOTICE OF APPEARANCE by William Paul Deni, Jr on behalf of Kaken Pharmaceutical Co., Ltd.. (Deni, William) |
| Sep 10, 2018 | 4 | AO 120 Form Patent/Trademark - Notice of Submission by Attorney (2) Docket Text: AO 120 FORM PATENT - NOTICE OF SUBMISSION BY ATTORNEY. AO 120 Form Patent/Trademark for case opening submitted to court for review.(Jantzi, Nicole) |
| Sep 10, 2018 | 3 | Rule 7.1 Corporate Disclosure Statement (2) Docket Text: RULE 7.1 CORPORATE DISCLOSURE STATEMENT. Identifying Corporate Parent Bausch Health Companies Inc. for Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC. Document filed by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd., Valeant Pharmaceuticals North America LLC.(Jantzi, Nicole) |
| Sep 10, 2018 | 2 | Civil Cover Sheet (2) Docket Text: CIVIL COVER SHEET filed. (Jantzi, Nicole) |
| Sep 10, 2018 | 1 | Exhibit H (11) |
| Sep 10, 2018 | 1 | Exhibit G (17) |
| Sep 10, 2018 | 1 | Exhibit F (14) |
| Sep 10, 2018 | 1 | Exhibit E (11) |
| Sep 10, 2018 | 1 | Exhibit D (17) |
| Sep 10, 2018 | 1 | Exhibit C (17) |
| Sep 10, 2018 | 1 | Main Document (23) Docket Text: COMPLAINT against PAR Pharmaceutical, Inc.. (Filing Fee $ 400.00, Receipt Number 0208-15549615)Document filed by Valeant Pharmaceuticals North America LLC, Kaken Pharmaceutical Co., Ltd., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H)(Jantzi, Nicole) |
| Sep 10, 2018 | 1 | Exhibit B (16) |
| Sep 10, 2018 | 1 | Exhibit A (15) |
| Sep 10, 2018 | 1 | Complaint (23) |
